s6y
Company name or ticker
Search
Aurinia Pharmaceuticals Inc.
DEF 14A
Definitive proxy statements
Filed
Tuesday, April 21, 2026
Period
Jun 3, 2026
Accession number
0001600620-26-000039
Documents
DEF 14A
DEF 14A
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
EX-101.SCH
On sec.gov
Filing index
All files
Complete submission text
SGML header